These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 341834)

  • 1. [The treatment of imminent abortion with monitoring of the maternal serum HPL level (proceedings)].
    Berle P; Behnke K
    Arch Gynakol; 1977 Jul; 224(1-4):90-1. PubMed ID: 341834
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is there any evidence that the maternal HPL serum-concentration is of prognostic value in cases of threatened abortion? (author's transl)].
    Berle P; Behnke K
    Z Geburtshilfe Perinatol; 1977 Jun; 181(3):211-7. PubMed ID: 888497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation of measurements of maternal serum hCG, hPL and progesterone as prognostic markers of abortion in early pregnancy.
    Sugita N; Yamaji K; Takagi T; Chiba Y; Tanizawa O
    Asia Oceania J Obstet Gynaecol; 1983 Mar; 9(1):49-54. PubMed ID: 6860237
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence of serum HPL level for prognosis of threatening abortion].
    Tykal P; Rüssler R; Dittmar FW
    Arch Gynakol; 1975 Nov; 219(1-4):418-9. PubMed ID: 1243401
    [No Abstract]   [Full Text] [Related]  

  • 6. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortion.
    Kunz J; Keller PJ
    Br J Obstet Gynaecol; 1976 Aug; 83(8):640-4. PubMed ID: 60125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of human placental lactogen (HPL) levels in threatened abortion.
    Gartside MW; Tindall VR
    Br J Obstet Gynaecol; 1975 Apr; 82(4):303-9. PubMed ID: 1125152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol, estriol and human placental lactogen in serum in threatened abortion.
    Hertz JB; Larsen JF; Svenstrup B; Johnsen SG
    Acta Obstet Gynecol Scand; 1979; 58(4):365-70. PubMed ID: 525270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical value of radioimmunological HPL findings in the long-term care of threatened abortion].
    Ruckhäberle KE; Bilek K; Viehweg B; Kühndel K; Colditz U; Bär G
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():43-9. PubMed ID: 6242693
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum hCG, hPL and progesterone levels in threatened abortions (author's transl)].
    Sugita N; Yamaji K; Fujita M; Chiba Y; Otsuki Y; Takagi T; Tanizawa O; Kurachi K; Sasaki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):851-8. PubMed ID: 7240863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental lactogen (HPL) in serum in complicated early pregnancy.
    Ylikorkala O; Jouppila P
    J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1040-5. PubMed ID: 4761378
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1975 Jan; 121(2):257-61. PubMed ID: 46714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the outcome of pregnancy in threatened abortion by biochemical methods.
    Karjalainen O; Stenman U; Wichmann K; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(6):457-64. PubMed ID: 4140705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of HPL radioimmunoassay in normal and pathologic early pregnancy].
    Hör G; Wallner H; Pabst HW; Domanowsky W
    Nucl Med (Stuttg); 1975 Jan; 13(4):371-8. PubMed ID: 1114050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental lactogen levels in threatened abortion.
    Niven PA; Chard T
    Proc R Soc Med; 1973 Feb; 66(2):188. PubMed ID: 4714661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of hormonal treatment of threatened abortion].
    Skolicki Z
    Folia Med Cracov; 1980; 22(1):137-49. PubMed ID: 6254862
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Endocrine assessment of threatened abortion.
    Rewell RE
    J Clin Pathol; 1975 Sep; 28(9):757. PubMed ID: 1165313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioimmunological assessment of the placental lactogen concentration in threatened abortion].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6242695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.